恒瑞医药降脂药获批上市,四环医药1类新药获批临床,力诺药包宣布减持,太极集团布局司美格鲁肽生物类似药

谈医说药
Sep 09, 2025

博雅生物:公司与抚州高新区财投集团有限公司签署了《上海市产权交易合同》,将江西博雅欣和制药有限公司80%股权转让给抚州高新区财投集团有限公司。2025年9月8日,博雅欣和已完成相关工商变更登记手续。转让完成后,公司直接持有博雅欣和10.6869%股权,全资子公司江西博雅医药投资有限公司持有博雅欣和9.3131%股权,博雅欣和不再纳入公司合并报表范围。东方生物:全资子公司Healgen ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10